Drug
Tabirafusp Tedromer
Tabirafusp Tedromer: highest development phase Phase 3, developed by Kodiak Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kodiak Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tabirafusp tedromer NCT07734844 | Phase 3 | Diabetic Macular Edema (DME) |
Latest
No recent events.
Follow Tabirafusp Tedromer on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.